[HIP/PAP, a new drug for acute liver failure]

MeSH terms

• Acetaminophen / toxicity
• Acute Disease
• Animals
• Antigens, Neoplasm / adverse effects
• Antigens, Neoplasm / physiology*
• Antigens, Neoplasm / therapeutic use
• Biomarkers, Tumor / adverse effects
• Biomarkers, Tumor / physiology*
• Biomarkers, Tumor / therapeutic use
• Chemical and Drug Induced Liver Injury / drug therapy
• Chemical and Drug Induced Liver Injury / etiology
• Clinical Trials, Phase I as Topic
• Clinical Trials, Phase II as Topic
• Disease Models, Animal
• Drug Evaluation, Preclinical
• Hepatitis / drug therapy*
• Hepatitis / etiology
• Humans
• Lectins, C-Type / physiology*
• Lectins, C-Type / therapeutic use
• Liver Failure / drug therapy*
• Liver Regeneration
• Mice
• Mice, Inbred C57BL
• Mice, Transgenic
• Multicenter Studies as Topic
• Pancreatitis-Associated Proteins
• Reactive Oxygen Species / metabolism
• Recombinant Proteins / adverse effects
• Recombinant Proteins / therapeutic use
• fas Receptor / agonists